Free Trial

Climb Bio (CLYM) News Today

Climb Bio logo
$1.15 -0.06 (-4.96%)
As of 04:00 PM Eastern
Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board
Climb Bio, Inc. stock logo
Q2 Earnings Estimate for Climb Bio Issued By Leerink Partnrs
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Investment analysts at Leerink Partnrs upped their Q2 2025 earnings per share estimates for Climb Bio in a research report issued on Tuesday, March 25th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings of ($0.15) per s
What is Leerink Partnrs' Forecast for Climb Bio Q2 Earnings?
Climb Bio, Inc. stock logo
Climb Bio (NASDAQ:CLYM) Releases Earnings Results, Beats Estimates By $0.02 EPS
Climb Bio (NASDAQ:CLYM - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02.
Climb Bio, Inc. stock logo
Climb Bio (CLYM) Expected to Announce Earnings on Thursday
Climb Bio (NASDAQ:CLYM) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports.
Climb Bio, Inc. stock logo
Climb Bio (NASDAQ:CLYM) Shares Down 6.9% - Should You Sell?
Climb Bio (NASDAQ:CLYM) Trading Down 6.9% - What's Next?
Climb Bio to Present at Upcoming Investor Conferences
Climb Bio appoints Perrin Wilson as CBO
Climb Bio, Inc. stock logo
Climb Bio FY2025 EPS Forecast Decreased by Leerink Partnrs
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Equities researchers at Leerink Partnrs lowered their FY2025 earnings estimates for shares of Climb Bio in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($0.66) per share for the
Climb Bio, Inc. stock logo
Leerink Partnrs Comments on Climb Bio FY2029 Earnings
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Research analysts at Leerink Partnrs issued their FY2029 earnings estimates for Climb Bio in a report released on Wednesday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings of ($2.73) per share for the ye
Climb Bio, Inc. stock logo
Climb Bio (NASDAQ:CLYM) Trading Down 0.5% - Should You Sell?
Climb Bio (NASDAQ:CLYM) Trading Down 0.5% - Time to Sell?
Leerink Partners Sticks to Its Buy Rating for Climb Bio (CLYM)
Climb Bio Inc (CLYM)
Climb Bio to be added to Nasdaq Biotechnology Index
Climb Bio to be Added to the Nasdaq Biotechnology Index
Climb Bio, Inc. stock logo
Leerink Partnrs Comments on Climb Bio FY2024 Earnings
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Equities researchers at Leerink Partnrs issued their FY2024 earnings per share estimates for shares of Climb Bio in a research report issued on Monday, December 2nd. Leerink Partnrs analyst T. Smith expects that the company will post earnings per shar
Remove Ads
Get Climb Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLYM and its competitors with MarketBeat's FREE daily newsletter.

CLYM Media Mentions By Week

CLYM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLYM
News Sentiment

0.61

0.60

Average
Medical
News Sentiment

CLYM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLYM Articles
This Week

6

1

CLYM Articles
Average Week

Remove Ads
Get Climb Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLYM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CLYM) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners